Skip to main content
Top
Published in: BMC Infectious Diseases 1/2021

Open Access 01-12-2021 | Acute Kidney Injury | Research article

Campylobacter-associated hospitalisations in an Australian provincial setting

Authors: Cameron R. M. Moffatt, Karina J. Kennedy, Linda Selvey, Martyn D. Kirk

Published in: BMC Infectious Diseases | Issue 1/2021

Login to get access

Abstract

Background

Campylobacter spp. infections are a globally important cause of enterocolitis, causing substantial morbidity. Capturing accurate information on hospitalisations is challenging and limited population-level data exist to describe the clinico-epidemiological characteristics of hospitalised cases.

Methods

Hospital administrative and laboratory datasets were linked to identify Campylobacter-associated hospitalisations between 2004 and 2013. Accuracy of morbidity coding was assessed using laboratory diagnosis as a gold standard, with health department surveillance data used to calculate population-based rates. Additional patient-level data were collected via review of medical records. Descriptive statistics were used to assess changes in rates and proportions and to assess relationships between key variables including age, length of stay, comorbidity and complications.

Results

In total 685 Campylobacter-associated hospital admissions were identified, with the sensitivity of morbidity coding 52.8% (95% CI 48.9–56.7%). The mean annual rate of hospitalisation was 13.6%. Hospitalisation rates were higher for females across most age-groups, while for both genders marked increases were observed for those aged ≥60 years. Median admission age was 39.5 years, with an average length of stay of 3.5 days. Comorbidities were present in 34.5% (237/685) of admissions, with these patients more likely to develop electrolyte disturbances, hypotension, renal impairment or acute confusion (all p < 0.001). Bacteraemia and acute kidney injury were observed in 4.1% (28/685) and 3.6% (23/685) of admissions, respectively. Inpatient mortality was low (0.15%).

Conclusion

Under reporting of Campylobacter-associated hospitalisations is substantial but can be improved through data linkage. We observed demographic differences among those hospitalised but further work is needed to determine risk factors and predictors for hospitalisation.
Literature
1.
go back to reference European Food Safety Authority and European Centre for Disease Prevention and Control (EFSA and ECDC). The European Union summary report on trends and sources of zoonoses, zoonotic agents and food-borne outbreaks in 2017. EFSa J. 2018;16(12):e05500.CrossRef European Food Safety Authority and European Centre for Disease Prevention and Control (EFSA and ECDC). The European Union summary report on trends and sources of zoonoses, zoonotic agents and food-borne outbreaks in 2017. EFSa J. 2018;16(12):e05500.CrossRef
2.
go back to reference Geissler AL, Bustos Carrillo F, Swanson K, et al. Increasing campylobacter infections, outbreaks, and antimicrobial resistance in the United States, 2004-2012. Clin Infect Dis. 2017;65(10):1624–31.PubMedCrossRef Geissler AL, Bustos Carrillo F, Swanson K, et al. Increasing campylobacter infections, outbreaks, and antimicrobial resistance in the United States, 2004-2012. Clin Infect Dis. 2017;65(10):1624–31.PubMedCrossRef
3.
go back to reference Moffatt CR, Glass K, Stafford R, D'Este C, Kirk MD. The campylobacteriosis conundrum - examining the incidence of infection with Campylobacter sp. in Australia, 1998-2013. Epidemiol Infect. 2017;145(4):839–47.PubMedCrossRef Moffatt CR, Glass K, Stafford R, D'Este C, Kirk MD. The campylobacteriosis conundrum - examining the incidence of infection with Campylobacter sp. in Australia, 1998-2013. Epidemiol Infect. 2017;145(4):839–47.PubMedCrossRef
4.
go back to reference Blaser MJ, Engberg J. Clinical aspects of campylobacter jejuni and campylobacter coli infections. Campylobacter, Third Edition: American Society of Microbiology; 2008. p. 99–121. Blaser MJ, Engberg J. Clinical aspects of campylobacter jejuni and campylobacter coli infections. Campylobacter, Third Edition: American Society of Microbiology; 2008. p. 99–121.
5.
go back to reference Louwen R, van Baarlen P, van Vliet AH, van Belkum A, Hays JP, Endtz HP. Campylobacter bacteremia: a rare and under-reported event? Eur J Microbiol Immunol (Bp). 2012;2(1):76–87.CrossRef Louwen R, van Baarlen P, van Vliet AH, van Belkum A, Hays JP, Endtz HP. Campylobacter bacteremia: a rare and under-reported event? Eur J Microbiol Immunol (Bp). 2012;2(1):76–87.CrossRef
6.
go back to reference Pope JE, Krizova A, Garg AX, Thiessen-Philbrook H, Ouimet JM. Campylobacter reactive arthritis: a systematic review. Semin Arthritis Rheum. 2007;37(1):48–55.PubMedPubMedCentralCrossRef Pope JE, Krizova A, Garg AX, Thiessen-Philbrook H, Ouimet JM. Campylobacter reactive arthritis: a systematic review. Semin Arthritis Rheum. 2007;37(1):48–55.PubMedPubMedCentralCrossRef
7.
go back to reference Poropatich KO, Walker CL, Black RE. Quantifying the association between campylobacter infection and Guillain-Barre syndrome: a systematic review. J Health Popul Nutr. 2010;28(6):545–52.PubMedPubMedCentralCrossRef Poropatich KO, Walker CL, Black RE. Quantifying the association between campylobacter infection and Guillain-Barre syndrome: a systematic review. J Health Popul Nutr. 2010;28(6):545–52.PubMedPubMedCentralCrossRef
8.
go back to reference Thomas MK, Murray R, Flockhart L, et al. Estimates of foodborne illness-related hospitalizations and deaths in Canada for 30 specified pathogens and unspecified agents. Foodborne Pathog Dis. 2015;12(10):820–7.PubMedPubMedCentralCrossRef Thomas MK, Murray R, Flockhart L, et al. Estimates of foodborne illness-related hospitalizations and deaths in Canada for 30 specified pathogens and unspecified agents. Foodborne Pathog Dis. 2015;12(10):820–7.PubMedPubMedCentralCrossRef
10.
11.
go back to reference Australian Bureau of Statistics (ABS). Australian Demographic Statistics, June Quarter 2017. Accessed 12 Sept. Australian Bureau of Statistics (ABS). Australian Demographic Statistics, June Quarter 2017. Accessed 12 Sept.
12.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRef
13.
go back to reference Ellis M. Preventing microbial translocation in haematological malignancy. Br J Haematol. 2004;125(3):282–93.PubMedCrossRef Ellis M. Preventing microbial translocation in haematological malignancy. Br J Haematol. 2004;125(3):282–93.PubMedCrossRef
14.
go back to reference Helms M, Simonsen J, Molbak K. Foodborne bacterial infection and hospitalization: a registry-based study. Clin Infect Dis. 2006;42(4):498–506.PubMedCrossRef Helms M, Simonsen J, Molbak K. Foodborne bacterial infection and hospitalization: a registry-based study. Clin Infect Dis. 2006;42(4):498–506.PubMedCrossRef
15.
go back to reference Scallan E, Griffin PM, McLean HQ, Mahon BE. Hospitalisations due to bacterial gastroenteritis: a comparison of surveillance and hospital discharge data. Epidemiol Infect. 2018;146(8):954–60.PubMedCrossRef Scallan E, Griffin PM, McLean HQ, Mahon BE. Hospitalisations due to bacterial gastroenteritis: a comparison of surveillance and hospital discharge data. Epidemiol Infect. 2018;146(8):954–60.PubMedCrossRef
16.
go back to reference Harvala H, Rosendal T, Lahti E, et al. Epidemiology of Campylobacter jejuni infections in Sweden, November 2011–October 2012: is the severity of infection associated with C. jejuni sequence type? Infect Ecol Epidemiol. 2016;6:31079.PubMed Harvala H, Rosendal T, Lahti E, et al. Epidemiology of Campylobacter jejuni infections in Sweden, November 2011–October 2012: is the severity of infection associated with C. jejuni sequence type? Infect Ecol Epidemiol. 2016;6:31079.PubMed
17.
go back to reference The Institute of Environmental Science and Research Ltd. Notifiable Diseases In New Zealand: Annual Report 2017. Porirua, New Zealand, 2019. The Institute of Environmental Science and Research Ltd. Notifiable Diseases In New Zealand: Annual Report 2017. Porirua, New Zealand, 2019.
18.
19.
go back to reference Ruzante JM, Majowicz SE, Fazil A, Davidson VJ. Hospitalization and deaths for select enteric illnesses and associated sequelae in Canada, 2001-2004. Epidemiol Infect. 2011;139(6):937–45.PubMedCrossRef Ruzante JM, Majowicz SE, Fazil A, Davidson VJ. Hospitalization and deaths for select enteric illnesses and associated sequelae in Canada, 2001-2004. Epidemiol Infect. 2011;139(6):937–45.PubMedCrossRef
20.
go back to reference Olson CK, Ethelberg S, van Pelt W, Tauxe RV. Epidemiology of campylobacter jejuni infections in industrialized nations. Campylobacter, Third Edition: American Society of Microbiology; 2008. p. 163–89. Olson CK, Ethelberg S, van Pelt W, Tauxe RV. Epidemiology of campylobacter jejuni infections in industrialized nations. Campylobacter, Third Edition: American Society of Microbiology; 2008. p. 163–89.
21.
go back to reference Chen Y, Liu BC, Glass K, Kirk MD. High incidence of hospitalisation due to infectious gastroenteritis in older people associated with poor self-rated health. BMJ Open. 2015;5(12):e010161.PubMedPubMedCentralCrossRef Chen Y, Liu BC, Glass K, Kirk MD. High incidence of hospitalisation due to infectious gastroenteritis in older people associated with poor self-rated health. BMJ Open. 2015;5(12):e010161.PubMedPubMedCentralCrossRef
22.
go back to reference Christensen KL, Holman RC, Steiner CA, Sejvar JJ, Stoll BJ, Schonberger LB. Infectious disease hospitalizations in the United States. Clin Infect Dis. 2009;49(7):1025–35.PubMedCrossRef Christensen KL, Holman RC, Steiner CA, Sejvar JJ, Stoll BJ, Schonberger LB. Infectious disease hospitalizations in the United States. Clin Infect Dis. 2009;49(7):1025–35.PubMedCrossRef
23.
go back to reference Nichols GL, Richardson JF, Sheppard SK, Lane C, Sarran C. Campylobacter epidemiology: a descriptive study reviewing 1 million cases in England and Wales between 1989 and 2011. BMJ Open 2012; 2(4). Nichols GL, Richardson JF, Sheppard SK, Lane C, Sarran C. Campylobacter epidemiology: a descriptive study reviewing 1 million cases in England and Wales between 1989 and 2011. BMJ Open 2012; 2(4).
25.
go back to reference White AE, Ciampa N, Chen Y, et al. Characteristics of campylobacter and Salmonella infections and acute gastroenteritis in older adults in Australia, Canada, and the United States. Clin Infect Dis. 2019;69(9):1545–52.PubMedPubMedCentralCrossRef White AE, Ciampa N, Chen Y, et al. Characteristics of campylobacter and Salmonella infections and acute gastroenteritis in older adults in Australia, Canada, and the United States. Clin Infect Dis. 2019;69(9):1545–52.PubMedPubMedCentralCrossRef
26.
go back to reference Samuel MC, Vugia DJ, Shallow S, et al. Epidemiology of sporadic campylobacter infection in the United States and declining trend in incidence, FoodNet 1996-1999. Clin Infect Dis. 2004;38(Suppl 3):S165–74.PubMedCrossRef Samuel MC, Vugia DJ, Shallow S, et al. Epidemiology of sporadic campylobacter infection in the United States and declining trend in incidence, FoodNet 1996-1999. Clin Infect Dis. 2004;38(Suppl 3):S165–74.PubMedCrossRef
27.
go back to reference Jansen A, Stark K, Kunkel J, et al. Aetiology of community-acquired, acute gastroenteritis in hospitalised adults: a prospective cohort study. BMC Infect Dis. 2008;8:143.PubMedPubMedCentralCrossRef Jansen A, Stark K, Kunkel J, et al. Aetiology of community-acquired, acute gastroenteritis in hospitalised adults: a prospective cohort study. BMC Infect Dis. 2008;8:143.PubMedPubMedCentralCrossRef
28.
go back to reference Nielsen H, Hansen K, Gradel K, et al. Bacteraemia as a result of campylobacter species: a population-based study of epidemiology and clinical risk factors. Clin Microbiol Infect. 2010;16(1):57–61.PubMedCrossRef Nielsen H, Hansen K, Gradel K, et al. Bacteraemia as a result of campylobacter species: a population-based study of epidemiology and clinical risk factors. Clin Microbiol Infect. 2010;16(1):57–61.PubMedCrossRef
29.
go back to reference Kraaijvanger N, Rijpsma D, van Leeuwen H, Edwards M. Self-referrals in the emergency department: reasons why patients attend the emergency department without consulting a general practitioner first-a questionnaire study. Int J Emerg Med. 2015;8(1):46.PubMedPubMedCentralCrossRef Kraaijvanger N, Rijpsma D, van Leeuwen H, Edwards M. Self-referrals in the emergency department: reasons why patients attend the emergency department without consulting a general practitioner first-a questionnaire study. Int J Emerg Med. 2015;8(1):46.PubMedPubMedCentralCrossRef
30.
go back to reference Bradshaw C, Zheng Y, Silver SA, Chertow GM, Long J, Anand S. Acute kidney injury due to diarrheal illness requiring hospitalization: data from the National Inpatient Sample. J Gen Intern Med. 2018;33(9):1520–7.PubMedPubMedCentralCrossRef Bradshaw C, Zheng Y, Silver SA, Chertow GM, Long J, Anand S. Acute kidney injury due to diarrheal illness requiring hospitalization: data from the National Inpatient Sample. J Gen Intern Med. 2018;33(9):1520–7.PubMedPubMedCentralCrossRef
31.
go back to reference Neal KR, Slack RC. Diabetes mellitus, anti-secretory drugs and other risk factors for campylobacter gastro-enteritis in adults: a case-control study. Epidemiol Infect. 1997;119(3):307–11.PubMedPubMedCentralCrossRef Neal KR, Slack RC. Diabetes mellitus, anti-secretory drugs and other risk factors for campylobacter gastro-enteritis in adults: a case-control study. Epidemiol Infect. 1997;119(3):307–11.PubMedPubMedCentralCrossRef
32.
go back to reference Gradel KO, Schonheyder HC, Dethlefsen C, Kristensen B, Ejlertsen T, Nielsen H. Morbidity and mortality of elderly patients with zoonotic Salmonella and campylobacter: a population-based study. J Inf Secur. 2008;57(3):214–22. Gradel KO, Schonheyder HC, Dethlefsen C, Kristensen B, Ejlertsen T, Nielsen H. Morbidity and mortality of elderly patients with zoonotic Salmonella and campylobacter: a population-based study. J Inf Secur. 2008;57(3):214–22.
33.
go back to reference Pacanowski J, Lalande V, Lacombe K, et al. Campylobacter bacteremia: clinical features and factors associated with fatal outcome. Clin Infect Dis. 2008;47(6):790–6.PubMedCrossRef Pacanowski J, Lalande V, Lacombe K, et al. Campylobacter bacteremia: clinical features and factors associated with fatal outcome. Clin Infect Dis. 2008;47(6):790–6.PubMedCrossRef
34.
go back to reference Hussein K, Raz-Pasteur A, Shachor-Meyouhas Y, et al. Campylobacter bacteraemia: 16 years of experience in a single Centre. Infect Dis (Lond). 2016;48(11–12):796–9.CrossRef Hussein K, Raz-Pasteur A, Shachor-Meyouhas Y, et al. Campylobacter bacteraemia: 16 years of experience in a single Centre. Infect Dis (Lond). 2016;48(11–12):796–9.CrossRef
35.
go back to reference Ena J, Afonso-Carrillo RG, Bou-Collado M, et al. Epidemiology of severe acute diarrhea in patients requiring hospital admission. J Emerg Med. 2019;57(3):290–8.PubMedCrossRef Ena J, Afonso-Carrillo RG, Bou-Collado M, et al. Epidemiology of severe acute diarrhea in patients requiring hospital admission. J Emerg Med. 2019;57(3):290–8.PubMedCrossRef
36.
go back to reference Janssen van Doorn K, Pierard D, Spapen H. Acute renal dysfunction in Salmonella gastroenteritis. J Clin Gastroenterol. 2006;40(10):910–2.PubMedCrossRef Janssen van Doorn K, Pierard D, Spapen H. Acute renal dysfunction in Salmonella gastroenteritis. J Clin Gastroenterol. 2006;40(10):910–2.PubMedCrossRef
37.
go back to reference Campbell LK, Havens JM, Scott MA, Lamps LWJMP. Molecular detection of Campylobacter jejuni in archival cases of acute appendicitis 2006; 19(8): 1042–1046. Campbell LK, Havens JM, Scott MA, Lamps LWJMP. Molecular detection of Campylobacter jejuni in archival cases of acute appendicitis 2006; 19(8): 1042–1046.
39.
go back to reference Ailes E, Scallan E, Berkelman RL, Kleinbaum DG, Tauxe RV, Moe CL. Do differences in risk factors, medical care seeking, or medical practices explain the geographic variation in campylobacteriosis in foodborne diseases active surveillance network (FoodNet) sites? Clin Infect Dis. 2012;54(Suppl 5):S464–71.PubMedCrossRef Ailes E, Scallan E, Berkelman RL, Kleinbaum DG, Tauxe RV, Moe CL. Do differences in risk factors, medical care seeking, or medical practices explain the geographic variation in campylobacteriosis in foodborne diseases active surveillance network (FoodNet) sites? Clin Infect Dis. 2012;54(Suppl 5):S464–71.PubMedCrossRef
40.
go back to reference Australian Institute of Health and Welfare (AIHW). Australia's health 2014. Canberra: AIHW. p. 2014. Australian Institute of Health and Welfare (AIHW). Australia's health 2014. Canberra: AIHW. p. 2014.
41.
go back to reference Canaway R, Boyle DI, Manski-Nankervis JE, et al. Gathering data for decisions: best practice use of primary care electronic records for research. Med J Aust. 2019;210(Suppl 6):S12–S6.PubMedPubMedCentral Canaway R, Boyle DI, Manski-Nankervis JE, et al. Gathering data for decisions: best practice use of primary care electronic records for research. Med J Aust. 2019;210(Suppl 6):S12–S6.PubMedPubMedCentral
42.
go back to reference Kellum JA, Lameire N, Aspelin P, et al. Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO Clin Practice Guideline Acute Kidney Injury. 2012;2(1):1–138. Kellum JA, Lameire N, Aspelin P, et al. Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO Clin Practice Guideline Acute Kidney Injury. 2012;2(1):1–138.
Metadata
Title
Campylobacter-associated hospitalisations in an Australian provincial setting
Authors
Cameron R. M. Moffatt
Karina J. Kennedy
Linda Selvey
Martyn D. Kirk
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2021
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-020-05694-0

Other articles of this Issue 1/2021

BMC Infectious Diseases 1/2021 Go to the issue